Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-16

FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Camber Pharmaceuticals' generic drospirenone/ethinyl estradiol, making this combined oral contraceptive available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DROSPIRENONE AND ETHINYL ESTRADIOL (drospirenone and ethinyl estradiol)

Snippet

SUPPL AP for DROSPIRENONE AND ETHINYL ESTRADIOL (DROSPIRENONE AND ETHINYL ESTRADIOL)